These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver]. Zuckerman E; Safadi R; Oren R; Shibolet O; Baruch Y; Bruck R; Lurei Y; Kaspa RT; Abu-Mouch S; Shouval D; Ben-Ari Z; Harefuah; 2012 Dec; 151(12):709-14, 719. PubMed ID: 23330266 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus treatment pre- and post-liver transplantation. Roche B; Samuel D Liver Int; 2012 Feb; 32 Suppl 1():120-8. PubMed ID: 22212582 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy of triple therapy in patients with chronic hepatitis C not treated and patients previously treated ineffectively]. Kozielewicz D; Halota W; Dybowska D Przegl Epidemiol; 2012; 66(1):49-54. PubMed ID: 22708298 [TBL] [Abstract][Full Text] [Related]
9. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives. Welsch C; Jesudian A; Zeuzem S; Jacobson I Gut; 2012 May; 61 Suppl 1():i36-46. PubMed ID: 22504918 [TBL] [Abstract][Full Text] [Related]
10. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C. Jacobson IM; Pawlotsky JM; Afdhal NH; Dusheiko GM; Forns X; Jensen DM; Poordad F; Schulz J J Viral Hepat; 2012 May; 19 Suppl 2():1-26. PubMed ID: 22404758 [TBL] [Abstract][Full Text] [Related]
11. [Boceprevir: new possibilities for antiviral treatment of chronic hepatitis C]. Nikitin IG; Baĭkova IE; Gogova LM; Volynkina VM; Kisliakov VA Ter Arkh; 2013; 85(2):76-84. PubMed ID: 23653945 [TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
13. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [TBL] [Abstract][Full Text] [Related]
14. New developments in HCV therapy. Kronenberger B; Zeuzem S J Viral Hepat; 2012 Jan; 19 Suppl 1():48-51. PubMed ID: 22233414 [TBL] [Abstract][Full Text] [Related]
16. Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection. Trembling PM; Tanwar S; Dusheiko GM Expert Rev Anti Infect Ther; 2012 Mar; 10(3):269-79. PubMed ID: 22397560 [TBL] [Abstract][Full Text] [Related]
17. Future of hepatitis C therapy: development of direct-acting antivirals. Dore GJ; Matthews GV; Rockstroh J Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228 [TBL] [Abstract][Full Text] [Related]
18. Treating hepatitis C infection in liver transplant recipients. Terrault NA; Berenguer M Liver Transpl; 2006 Aug; 12(8):1192-204. PubMed ID: 16868944 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of chronic hepatitis C virus infection at the beginning of a new era]. Urbánek P Vnitr Lek; 2013 Jul; 59(7):612-7. PubMed ID: 23909268 [TBL] [Abstract][Full Text] [Related]